Variagenics' Acquisition

Variagenics was acquired by Nuvelo on January 21, 2003.

Variagenics, Inc. applies its pharmacogenomic technologies to the discovery, development and commercialization of personalized drugs and companion molecular diagnostic products. Using a targeted drug …

Articles about Variagenics' Acquisition: